Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML) Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company focused on developing innovative therapeutics targeting diseases with high unmet medical needs, announced significant updates today regarding its lead investigational…
Signios Biosciences Unveils Rebrand and Expands Vision as a Leading Multiomics and AI Bioinformatics Innovator in Precision Medicine In a bold step forward reflecting its evolution and expanded capabilities, Signios Biosciences (formerly the U.S.-based research division of MedGenome Inc.) has…
Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients Landmark Clinical Trial Finds Certolizumab Significantly Improves Pregnancy Outcomes in Women with Antiphospholipid Syndrome In a groundbreaking advancement for maternal-fetal medicine and autoimmune disease treatment, a phase 2 clinical trial co-led…
Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access Textron Aviation Inc., a renowned aircraft manufacturer and a subsidiary of Textron Inc. (NYSE: TXT), has announced the opening of its second Plane…
Global Forecast: mRNA Vaccines & Therapeutics Market for Influenza, RSV, and CMV (2025) A new report titled “mRNA Vaccine and Therapeutics Market: Industry Trends and Global Forecasts to 2035 by Application Area, Target Disease Indication, and Geographical Regions” has been…
IBL International Partners with Grifols to Develop Cutting-Edge Biomarker Panels IBL International GmbH, a Tecan Group company renowned for its expertise in specialty diagnostics, has officially announced a strategic partnership with Grifols, a global healthcare leader with a legacy in…
Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer Alpenglow Biosciences, a leading innovator in 3D spatial biology and digital pathology, is pleased to announce its exclusive Dinner Lecture during the American Association for Cancer…
Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise, today announced the appointment of Laura Sepp-Lorenzino, Ph.D., to its…
Hello Heart Launches Smart Pill Box to Transform Medication Adherence In a significant step forward for digital heart health management, Hello Heart, the leading digital platform for preventive heart care, has announced the release of its latest innovation: the Hello…
Prollenium Announces Leadership Transition Prollenium Medical Technologies (“Prollenium” or “the Company”), a leading innovator in the aesthetic medical space, has announced a significant leadership change as Ario Khoshbin, its Founder and longstanding Chief Executive Officer, has decided to step down…
Prollenium Unveils New Leadership Structure In a significant leadership transition aimed at fostering continued growth and innovation, Prollenium Medical Technologies (“Prollenium” or “the Company”) has announced that Ario Khoshbin, the Company’s longtime Chief Executive Officer, will be stepping down from…
Hologic Appoints Wayde McMillan to Board of Directors Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment, has announced the election of Wayde McMillan to its Board…
